Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
02/2000
02/02/2000EP0975752A1 Human cerberus protein
02/02/2000EP0975751A1 A tm4sf human tumor-associated antigen
02/02/2000EP0975750A2 Modified retinoblastoma tumor suppressor proteins
02/02/2000EP0975745A1 Extracellular expression of cellulose binding domains (cbd) using bacillus
02/02/2000EP0975738A1 A new microorganism streptomyces exfoliatus yj-118 and a method for producing pravastatin sodium by using the strain
02/02/2000EP0975737A1 $i(CHLORELLA) VIRUS PROMOTERS
02/02/2000EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof
02/02/2000EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA
02/02/2000EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer
02/02/2000EP0975664A1 Aatt promoter element and transcription factor
02/02/2000EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease
02/02/2000EP0777683B1 Antiprotozoal cyclic tetrapeptides
02/02/2000EP0775210B1 Mutated penicillin g acylase genes
02/02/2000EP0752472B1 Gene originating in corynebacterium and use thereof
02/02/2000EP0729580B1 Method of identifying hdm-2-specific antibodies
02/02/2000EP0713532B1 Modified maxadilan protein, its preparation and use, and dna encoding the protein
02/02/2000EP0539530B1 Purification directed cloning of peptides
02/02/2000EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
02/02/2000CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
02/02/2000CN1243130A Preparation method for engineering bateria for recombination of human leucocyte medium-18 and its product thereof
02/01/2000US6020478 Human tumor-associated antigen
02/01/2000US6020474 ATP synthase subunits
02/01/2000US6020464 Isolated Smad protein
02/01/2000US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
02/01/2000US6020306 Receptor-type tyrosine kinase and use thereof
02/01/2000US6020200 Encapsulation compositions and methods
02/01/2000US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use
02/01/2000US6020180 C. antarctica lipase and lipase variants
02/01/2000US6020179 Nucleic acids encoding human tyrosine phosphatases
02/01/2000US6020177 Heptaprenyl diphosphate-synthetase
02/01/2000US6020176 Converting copalyl pyrophosphate to ent-kaurene and are useful for the regulation of plant growth.
02/01/2000US6020171 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof
02/01/2000US6020166 Nucleic acid encoding an altered telomere repeat binding factor 2
02/01/2000US6020165 Cytikine signal regulators
02/01/2000US6020164 Human RNA binding proteins
02/01/2000US6020159 3-dehydroquinate synthase
02/01/2000US6020152 Lymphocyte-associated cell surface protein
02/01/2000US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses.
02/01/2000US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
02/01/2000US6020133 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use
02/01/2000US6020129 Stilbene synthase gene
02/01/2000US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh.
02/01/2000CA2183275C Biological control of plant disease on roots of conifer seedlings
02/01/2000CA2171982C Drug binding protein
02/01/2000CA2069085C Activatable fibrinolytic and anti-thrombotic proteins
02/01/2000CA2047681C Vaccines for nontypable haemophilus influenzae
01/2000
01/27/2000WO2000004183A1 Bone morphogenic protein
01/27/2000WO2000004182A1 Process and materials for production of glucosamine
01/27/2000WO2000004180A1 Bio-reaction process and product
01/27/2000WO2000004179A1 Stereoselective reductive amination of ketones
01/27/2000WO2000004176A1 Process to collect metabolites from modified nectar by insects
01/27/2000WO2000004172A1 Method of making proteins in transformed yeast cells
01/27/2000WO2000004169A1 New caspase homologue
01/27/2000WO2000004166A2 Plant cellulose synthases
01/27/2000WO2000004160A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
01/27/2000WO2000004159A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
01/27/2000WO2000004158A2 Compositions and methods for fumonisin detoxification
01/27/2000WO2000004156A2 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES)
01/27/2000WO2000004152A2 Androgen receptor coactivators
01/27/2000WO2000004150A1 Human presenilin-associated protein
01/27/2000WO2000004148A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
01/27/2000WO2000004141A2 Use of nucleic acid molecules as antiviral agents
01/27/2000WO2000004140A1 71 human secreted proteins
01/27/2000WO2000004137A1 Human aspartic proteases
01/27/2000WO2000004136A1 Glucoamylase variants
01/27/2000WO2000004134A1 Novel gene and transformant carrying the same
01/27/2000WO2000004050A2 Neurotrophic growth factor
01/27/2000WO2000004045A1 Axor10, a g-protein coupled receptor
01/27/2000WO2000004043A1 Protease susceptibility ii
01/27/2000WO2000004041A2 Methods and molecules relating to cd39-like polypeptides
01/27/2000WO2000003726A1 Lysine binding fragments of angiostatin
01/27/2000WO2000003722A1 Nocathiacin antibiotics
01/27/2000WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions
01/27/2000WO2000003581A1 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity
01/27/2000WO1999063096A3 Acyl coa:cholesterol acyltransferase related nucleic acid sequences
01/27/2000WO1999061639A3 Retroviral delivery system
01/27/2000WO1999061623A3 Genetic method for producing riboflavin
01/27/2000WO1999061599A3 Recombinant narbonolide polyketide synthase
01/27/2000WO1999061064A8 Mammalian genes encoding 3'-5' exonuclease
01/27/2000WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof
01/27/2000WO1999058682A3 Compounds from moraxella catarrhalis
01/27/2000WO1999054465A9 Gene encoding syntaxin interacting protein
01/27/2000WO1999052925A9 Programmed cell death and caspase-12
01/27/2000WO1999023227A9 Hyaluronan synthase gene and uses thereof
01/27/2000CA2337843A1 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity
01/27/2000CA2337835A1 Potassium channel polypeptide and polynucleotide compositions
01/27/2000CA2337635A1 Method of making proteins in transformed yeast cells
01/27/2000CA2337398A1 Nocathiacin antibiotics
01/27/2000CA2337231A1 Lysine binding fragments of angiostatin
01/27/2000CA2337230A1 Stereoselective reductive amination of ketones
01/27/2000CA2335274A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
01/27/2000CA2335101A1 Androgen receptor coactivators
01/27/2000CA2335099A1 New caspase homologue
01/27/2000CA2335096A1 Methods and materials relating to novel cd39-like polypeptides
01/27/2000CA2334161A1 Use of nucleic acid molecules as antiviral agents
01/27/2000CA2334075A1 Bone morphogenic protein
01/27/2000CA2333917A1 71 human secreted proteins
01/27/2000CA2333910A1 Neurotrophic growth factor
01/27/2000CA2333897A1 Process to collect metabolites from modified nectar by insects
01/27/2000CA2333856A1 Serotype-specific probes for listeria monocytogenes